Literature DB >> 20053989

A tyrosine-based motif localizes a Drosophila vesicular transporter to synaptic vesicles in vivo.

Anna Grygoruk1, Hao Fei, Richard W Daniels, Bradley R Miller, Aaron Diantonio, David E Krantz.   

Abstract

Vesicular neurotransmitter transporters must localize to synaptic vesicles (SVs) to allow regulated neurotransmitter release at the synapse. However, the signals required to localize vesicular proteins to SVs in vivo remain unclear. To address this question we have tested the effects of mutating proposed trafficking domains in Drosophila orthologs of the vesicular monoamine and glutamate transporters, DVMAT-A and DVGLUT. We show that a tyrosine-based motif (YXXY) is important both for DVMAT-A internalization from the cell surface in vitro, and localization to SVs in vivo. In contrast, DVGLUT deletion mutants that lack a putative C-terminal trafficking domain show more modest defects in both internalization in vitro and trafficking to SVs in vivo. Our data show for the first time that mutation of a specific trafficking motif can disrupt localization to SVs in vivo and suggest possible differences in the sorting of VMATs versus VGLUTs to SVs at the synapse.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053989      PMCID: PMC2844137          DOI: 10.1074/jbc.M109.073064

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Interaction between the vesicular glutamate transporter type 1 and endophilin A1, a protein essential for endocytosis.

Authors:  Jacqueline Vinatier; Etienne Herzog; Marie-Aude Plamont; Sonja M Wojcik; Anne Schmidt; Nils Brose; Laurent Daviet; Salah El Mestikawy; Bruno Giros
Journal:  J Neurochem       Date:  2006-04-05       Impact factor: 5.372

2.  Identification of endophilins 1 and 3 as selective binding partners for VGLUT1 and their co-localization in neocortical glutamatergic synapses: implications for vesicular glutamate transporter trafficking and excitatory vesicle formation.

Authors:  Stephanie De Gois; Elisabeth Jeanclos; Marie Morris; Sukhjeevan Grewal; Helene Varoqui; Jeffrey D Erickson
Journal:  Cell Mol Neurobiol       Date:  2006-05-19       Impact factor: 5.046

3.  The expression pattern of the Drosophila vesicular glutamate transporter: a marker protein for motoneurons and glutamatergic centers in the brain.

Authors:  Andrea Mahr; Hermann Aberle
Journal:  Gene Expr Patterns       Date:  2005-12-27       Impact factor: 1.224

4.  Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling.

Authors:  Susan M Voglmaier; Kaiwen Kam; Hua Yang; Doris L Fortin; Zhaolin Hua; Roger A Nicoll; Robert H Edwards
Journal:  Neuron       Date:  2006-07-06       Impact factor: 17.173

5.  Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases.

Authors:  C Sagné; S El Mestikawy; M F Isambert; M Hamon; J P Henry; B Giros; B Gasnier
Journal:  FEBS Lett       Date:  1997-11-10       Impact factor: 4.124

6.  The vesicular monoamine transporter 2 contains trafficking signals in both its N-glycosylation and C-terminal domains.

Authors:  Jia Yao; Louis B Hersh
Journal:  J Neurochem       Date:  2007-01-08       Impact factor: 5.372

7.  Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine.

Authors:  H-Y Chang; A Grygoruk; E S Brooks; L C Ackerson; N T Maidment; R J Bainton; D E Krantz
Journal:  Mol Psychiatry       Date:  2006-01       Impact factor: 15.992

8.  A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine.

Authors:  Tzu-Kang Sang; Hui-Yun Chang; George M Lawless; Anuradha Ratnaparkhi; Lisa Mee; Larry C Ackerson; Nigel T Maidment; David E Krantz; George R Jackson
Journal:  J Neurosci       Date:  2007-01-31       Impact factor: 6.167

9.  The cytoplasmic tail of the vesicular acetylcholine transporter contains a synaptic vesicle targeting signal.

Authors:  H Varoqui; J D Erickson
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

10.  Dileucine motif is sufficient for internalization and synaptic vesicle targeting of vesicular acetylcholine transporter.

Authors:  Lesley Colgan; Hao Liu; Steven Y Huang; Yong-Jian Liu
Journal:  Traffic       Date:  2007-05       Impact factor: 6.215

View more
  5 in total

Review 1.  From glutamate co-release to vesicular synergy: vesicular glutamate transporters.

Authors:  Salah El Mestikawy; Asa Wallén-Mackenzie; Guillaume M Fortin; Laurent Descarries; Louis-Eric Trudeau
Journal:  Nat Rev Neurosci       Date:  2011-04       Impact factor: 34.870

2.  Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104.

Authors:  Jiaxing Li; Yao V Zhang; Elham Asghari Adib; Doychin T Stanchev; Xin Xiong; Susan Klinedinst; Pushpanjali Soppina; Thomas Robert Jahn; Richard I Hume; Tobias M Rasse; Catherine A Collins
Journal:  Elife       Date:  2017-09-19       Impact factor: 8.140

3.  Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration.

Authors:  Richard W Daniels; Bradley R Miller; Aaron DiAntonio
Journal:  Neurobiol Dis       Date:  2010-10-14       Impact factor: 5.996

4.  The redistribution of Drosophila vesicular monoamine transporter mutants from synaptic vesicles to large dense-core vesicles impairs amine-dependent behaviors.

Authors:  Anna Grygoruk; Audrey Chen; Ciara A Martin; Hakeem O Lawal; Hao Fei; Gabriel Gutierrez; Traci Biedermann; Rod Najibi; Richard Hadi; Amit K Chouhan; Niall P Murphy; Felix E Schweizer; Gregory T Macleod; Nigel T Maidment; David E Krantz
Journal:  J Neurosci       Date:  2014-05-14       Impact factor: 6.167

Review 5.  Drosophila melanogaster as a genetic model system to study neurotransmitter transporters.

Authors:  Ciara A Martin; David E Krantz
Journal:  Neurochem Int       Date:  2014-04-03       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.